Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Legend Biotech Corporation (DE:9LB)
FRANKFURT:9LB
Holding DE:9LB?
Track your performance easily
See the Price Targets and Ratings of:
9LB Analyst Ratings
Strong Buy
12 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
9LB Stock 12 Month Forecast
Average Price Target
€77.26
▲(70.94% Upside)
| Highest Price Target€86.18 | Average Price Target€77.26 | Lowest Price Target€61.43 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Barclays
Reiterated
10/15/24
Jefferies
Assigned
10/14/24
TD Cowen
Reiterated
10/11/24
Redburn Atlantic
Initiated
10/08/24
BMO Capital
Assigned
10/08/24
RBC Capital
Reiterated
10/04/24
H.C. Wainwright
Reiterated
10/04/24
Scotiabank
Reiterated
09/30/24
William Blair
Reiterated
09/30/24
Piper Sandler
Reiterated
09/30/24
Truist Financial
―
Buy
―
Assigned
08/13/24
Legend Biotech (LEGN) Receives a Buy from Truist Financial
BTIG
€83.43
Buy
84.59%
Upside
Reiterated
07/17/24
BTIG reiterates Buy Rating on Legend Biotech Corp. (LEGN)BTIG analyst Justin Zelin reiterated a Buy rating and $91.00 price target on Legend Biotech Corp. (NASDAQ: LEGN).
Deutsche Bank
€55.01
Buy
21.71%
Upside
Reiterated
07/02/24
Buy Rating Affirmed for Legend Biotech Amid Promising Carvykti Trial Results and Expert Endorsements
Morgan Stanley
€77.93→€75.18
Buy
66.33%
Upside
Reiterated
05/17/24
Legend Biotech Corp. (LEGN) PT Lowered to $82 at Morgan StanleyMorgan Stanley analyst Matthew Harrison lowered the price target on Legend Biotech Corp. (NASDAQ: LEGN) to $82.00 (from $85.00) while maintaining a Overweight rating.
Best Analysts Covering Legend Biotech
Which Analyst Should I Follow If I Want to Buy DE:9LB and Sell After:
1 Month
xxx
Success Rate
8/12 ratings generated profit
Average Return
+2.49%
reiterated a xxx
rating 16 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +2.49% per trade.
3 Months
xxx
Success Rate
6/10 ratings generated profit
Average Return
+14.04%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +14.04% per trade.
1 Year
Success Rate
8/10 ratings generated profit
Average Return
+26.84%
reiterated a buy rating 5 months ago
Copying Matthew Harrison's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +26.84% per trade.
2 Years
xxx
Success Rate
7/10 ratings generated profit
Average Return
+19.76%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 70.00% of your transactions generating a profit, with an average return of +19.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
9LB Analyst Recommendation Trends
Rating
Jun 24
Jul 24
Aug 24
Sep 24
Oct 24
Strong Buy
36
25
15
15
14
Buy
7
7
10
11
7
Hold
4
1
1
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
47
33
26
28
23
Each month's total comprises the sum of three months' worth of ratings.
9LB Financial Forecast
9LB Stock Forecast FAQ
What is DE:9LB’s average 12-month price target, according to analysts?
Based on analyst ratings, Legend Biotech Corporation’s 12-month average price target is €77.26.
What is DE:9LB’s upside potential, based on the analysts’ average price target?
Legend Biotech Corporation has 70.94% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Legend Biotech Corporation a Buy, Sell or Hold?
Legend Biotech Corporation has a consensus rating of Strong Buy, which is based on 12 buy ratings, 1 hold ratings and 0 sell ratings.
What is Legend Biotech Corporation’s share price target?
The average share price target for Legend Biotech Corporation is €77.26. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €86.18 ,and the lowest forecast is €61.43. The average share price target represents 70.94% Increase from the current price of €45.2.
The highest analyst share price target is €86.18 ,and the lowest forecast is €61.43. The average share price target represents 70.94% Increase from the current price of €45.2.
What do analysts say about Legend Biotech Corporation?
Legend Biotech Corporation’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of Legend Biotech Corporation?
To buy shares of DE:9LB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.